Prohibited Substance Case under FEI Anti-Doping Rules
Lausanne (SUI), 6 July 2017 – The FEI has announced an adverse analytical finding involving a prohibited substance.
The new case involves the use of Stanozolol, an anabolic steroid, which is a Banned Substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
Horse: Shiners Chic (FEI ID 103DF20/GBR)
Person Responsible: Jessica Sternberg (FEI ID 10055844/GBR)
Event: CRI3* – Katy, Texas (USA), 20-21.04.2017
Prohibited Substance: Stanozolol
The athlete has been provisionally suspended from the date of notification (5 July 2017) until the FEI Tribunal renders a decision. The horse has been provisionally suspended for two months.
FEI Media Contact:
Shannon Gibbons
Manager Press Relations
shannon.gibbons@fei.org
+41 78 750 61 46